Arcturus Therapeutics Holdings Inc.Arcturus Therapeutics Holdings Inc.Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc.

No trades
See on Supercharts

ARCT fundamentals

Key facts

Market capitalization

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.


Fundamental metrics to determine fair value of the stock

No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins


Dividend yield, history and sustainability

ARCT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company